Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
Johnson and Johnson
Healthtrust
UBS
Citi
QuintilesIMS
Deloitte
Harvard Business School
McKesson

Generated: November 18, 2018

DrugPatentWatch Database Preview

Ingenus Pharms Llc Company Profile

« Back to Dashboard

What is the competitive landscape for INGENUS PHARMS LLC, and what generic and branded alternatives to INGENUS PHARMS LLC drugs are available?

INGENUS PHARMS LLC has ten approved drugs.



Summary for Ingenus Pharms Llc
US Patents:0
Tradenames:10
Ingredients:10
NDAs:10

Drugs and US Patents for Ingenus Pharms Llc

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ingenus Pharms Llc DESIPRAMINE HYDROCHLORIDE desipramine hydrochloride TABLET;ORAL 204963-003 Dec 26, 2017 AB RX No No ➤ Sign Up ➤ Sign Up
Ingenus Pharms Llc TOLCAPONE tolcapone TABLET;ORAL 208937-001 Aug 7, 2018 AB RX No No ➤ Sign Up ➤ Sign Up
Ingenus Pharms Llc DESIPRAMINE HYDROCHLORIDE desipramine hydrochloride TABLET;ORAL 204963-002 Dec 26, 2017 AB RX No No ➤ Sign Up ➤ Sign Up
Ingenus Pharms Llc DOCETAXEL docetaxel INJECTABLE;INJECTION 207563-001 Aug 31, 2017 AP RX No No ➤ Sign Up ➤ Sign Up
Ingenus Pharms Llc IRINOTECAN HYDROCHLORIDE irinotecan hydrochloride INJECTABLE;INJECTION 206935-002 May 26, 2017 AP RX No No ➤ Sign Up ➤ Sign Up
Ingenus Pharms Llc DOCETAXEL docetaxel INJECTABLE;INJECTION 207563-002 Aug 31, 2017 AP RX No No ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
McKinsey
Accenture
Baxter
Cipla
Boehringer Ingelheim
UBS
Federal Trade Commission
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.